SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Guidroz Allyson

(Last) (First) (Middle)
3854 AMERICAN WAY , SUITE A

(Street)
BATON ROUGE LA 70816

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/24/2023
3. Issuer Name and Ticker or Trading Symbol
AMEDISYS INC [ AMED ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 5,134(1) D
Common Stock 1.5(2) I By 401(k) Plan
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (3) 07/25/2028 Common Stock 272 $95.76 D
Stock Option (Right to Buy) (4) 07/25/2029 Common Stock 640 $132.41 D
Stock Option (Right to Buy) (5) 07/25/2030 Common Stock 563 $214.74 D
Stock Option (Right to Buy) (6) 07/25/2031 Common Stock 590 $264 D
Explanation of Responses:
1. Includes 117 performance-based restricted stock units tied to a performance metric for the 2020 fiscal year, which was certified as achieved and subject to further time-based vesting on July 25,2024; 118 time-based restricted stock units ("RSUs") that vest on July 25, 2024; 60 time-based RSUs that vest on July 25, 2025; 406 time-based RSUs that vest on each of June 1, 2024, 2025 and 2026; 647 time-based RSUs that vest on each of May 3, 2024, 2025 and 2026; and 648 time-based RSUs that vest on May 3, 2027, assuming in each case that the Reporting Person remains continuously employed by the Issuer on each such vesting date.
2. The information in this report is based on a plan statement dated as of June 30, 2023.
3. All 272 stock options are fully vested and immediately exercisable.
4. All 640 stock options are fully vested and immediately exercisable.
5. The stock options are subject to time-based vesting conditions. 422 stock options are fully vested and immediately exercisable, and the remaining 141 stock options will vest on July 25, 2024, provided that the Reporting Person remains continuously employed by the Issuer on such date.
6. The stock options are subject to time-based vesting conditions. 295 stock options are fully vested and immediately exercisable, 147 stock options will vest on July 25, 2024, and 148 stock options will vest on July 25, 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
Remarks:
Exhibit 24.1 - Power of Attorney
Jennifer Guckert Griffin, pursuant to a power of attorney 09/05/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.